Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Misiani, R.
space
  arrow  Primi, D.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

GB Virus C Infection in Patients with Type II Mixed Cryoglobulinemia

right arrow Rocco Misiani, MD; Giovanni Mantero, PhD; Piermario Bellavita, MD; Luigi Mori, MSc; Omar Vicari, MSc; Donatella Marchesi, MD; and Daniele Primi, PhD

15 November 1997 | Volume 127 Issue 10 | Pages 891-894

Background: Hepatitis C virus (HCV) infection is present in most but not all patients with type II mixed cryoglobulinemia.

Objective: To investigate the role of GB virus C (GBV-C) in type II mixed cryoglobulinemia.

Design: Retrospective study of serum and cryoprecipitate samples.

Setting: Tertiary care hospital in Bergamo, Italy.

Patients: 58 cryoglobulinemic patients, 35 of whom were treated with interferon-{alpha}.

Measurements: GB virus C RNA was determined by a reverse-transcription polymerase chain reaction assay done by using primers derived from the conserved GBV-C helicase region.

Results: GB virus C RNA was detected in serum specimens from 23 of 58 cryoglobulinemic patients (40% [95% CI, 27% to 53%]) and 1 of 145 healthy blood donors (0.7%) (P < 0.001). Twenty of the 23 patients with GBV-C RNA were simultaneously infected with HCV. Unlike antibodies to HCV and HCV RNA, GBV-C RNA did not concentrate in cryoprecipitate in patients co-infected with GBV-C and HCV. Furthermore, the therapeutic effectiveness of interferon-{alpha} in patients with coinfection was related to the disappearance of HCV RNA but not GBV-C RNA from serum. None of 3 patients with GBV-C infection alone had detectable GBV-C RNA in cryoprecipitate.

Conclusions: Infection with GBV-C, usually associated with HCV, is common in patients with type II mixed cryoglobulinemia but is unlikely to have a primary role in this disease.

Author and Article Information
space

From Ospedali Riuniti di Bergamo, Bergamo, Italy; and Consorzio per le Biotecnologie, Spedali Civili di Brescia, Brescia, Italy.
Acknowledgments: The authors thank Dr. Domenico Fenili for the characterization of cryoglobulins and Paolo Misiani for assistance in the preparation of the manuscript.
Requests for Reprints: Piermario Bellavita, MD, Servizio di Immunoematologia e Centro Trasfusionale, Ospedali Riuniti di Bergamo, Largo Barozzi 1, 24128, Bergamo, Italy.
Current Author Addresses: Drs. Misiani and Marchesi: Divisione di Nefrologia e Dialisi, Ospedali Riuniti di Bergamo, Largo Barozzi 1, 24128 Bergamo, Italy.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
G. Morsica, G. Sitia, and D. Roccatello
GB Virus C and Hepatitis C Virus Infection in Patients with Mixed Cryoglobulinemia
Ann Intern Med, September 5, 2000; 133(5): 394 - 395.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.